Medical Equipment Procurement Benchmarking Guide

Benchmarking compares an organisation's procurement against others to identify where it is performing poorly. The appeal is obvious, but the practice is treacherous, because equipment purchases differ in specification, volume, service inclusion,,n and contract length in ways that make headline prices nearly meaningless when set side by side.

This guide sets out how to benchmark procurement usefully. It covers what can genuinely be compared and what cannot, how to normalise for specification and service inclusion, which non-price measures often matter more, where benchmarking data comes from, and how to act on a finding without assuming the comparator is doing it correctly. It is written for procurement, finance and clinical engineering teams across the UK, Europe, the US, the Gulf and South Africa.

What drives the decision — the short version

• Comparability — Same thing, same terms. Specification, volume, service and contract length must match before price means anything.

• Beyond price — Process measures matter. Cycle time, compliance and supplier performance often reveal more than unit cost.

• Interpretation — A gap is a question. It indicates something worth investigating, not automatically something wrong.

Why price comparison misleads

Two hospitals paying different amounts for what appears to be the same device are frequently buying different things. One price may include five years of servicing, installation, training and consumables; the other may be the device alone. One may reflect a hundred-unit commitment, the other a single purchase.

Contract length, payment terms, trade-in arrangements and bundled products all move headline figures without indicating anything about procurement quality. A benchmark that ignores them produces a number that feels authoritative and points in no useful direction, and acting on it can make things worse.

Some measures are more comparable than price. Procurement cycle time, the proportion of spend under contract, compliance with published criteria and supplier performance against agreed terms can all be compared with less distortion. WHO guidance on health technology management supports assessing procurement as a system, and standards from bodies such as MHRA and clinical guidance from NICE provide a shared baseline for comparison.

What is worth benchmarking

1. Normalised unit price. Comparable only once specification, volume, service inclusion and term are matched.

2. Whole-life cost. More meaningful than purchase price, though harder to obtain from comparators.

3. Procurement cycle time from approved need to usable capability, which is broadly comparable across organisations.

4. Spend under contract. The proportion of equipment spend covered by agreed terms rather than ad hoc purchase.

5. Compliance rate. How often procurements follow the organisation's own stated process.

6. Supplier performance. Delivery against agreed dates, response times and downtime, measured consistently.

7. Standardisation level. Number of variants per device category, which indicates estate discipline.

8. Rework rate. How often procurements are restarted, which reveals specification quality.

How the criteria are applied

How the cycle typically runs

1. The question being asked is defined, since benchmarking without one produces numbers and no action.
2. Comparators are chosen for genuine similarity in size, case mix and structure.
3. Specification, volume, service inclusion and contract length are normalised before comparison.
4. Non-price measures are gathered alongside cost, since they are usually more comparable.
5. Gaps are investigated rather than acted on, because the comparator may be the outlier.
6. Findings are translated into a specific change, or the exercise is recorded as inconclusive.

A gap is a question, not a verdict.

The most common benchmarking error is treating a difference as a finding. An organisation paying more than a comparator may be buying a higher specification for good clinical reasons, holding a service arrangement the comparator lacks, or operating at a scale that genuinely costs more. The gap indicates something worth understanding.

It is equally possible that the comparator is the anomaly, having secured terms unavailable elsewhere or accepted a specification that would not meet local requirements. Investigating before acting is what separates benchmarking from imitation. Where a gap is genuine and unexplained, that is a strong basis for change; where it dissolves on examination, recording why is useful in itself.

What makes benchmarking useful

• A defined question. What the exercise is meant to answer, agreed before data is gathered.

• Genuinely similar comparators. Matched for size, case mix and structure rather than chosen for availability.

• Normalised comparisons. Specification, volume, service inclusion and term aligned before price is compared.

• Non-price measures included. Cycle time, compliance and supplier performance, which distort less than cost.

• Investigation before action. Gaps examined for explanation rather than treated as automatic findings.

• A recorded conclusion. Including where the exercise proved inconclusive, so it is not repeated identically.

Where benchmarking data comes from

Sources vary in quality. Collaborative purchasing bodies and clinical networks often hold comparable data and understand its limitations. Commercial benchmarking services offer breadth but may normalise poorly. Informal exchange between peers is frequently the most accurate and the least systematic, which limits what can be built on it.

Whatever the source, the constraint is usually the comparability of the underlying records rather than access to them. Organisations whose own data is inconsistent cannot benchmark reliably even with perfect comparators. ISO standards for quality management support the record consistency that makes comparison possible in the first place.

More from Business

• Buyers — source compliant, well-documented equipment.

• Suppliers — list your equipment and reach buyers worldwide.

Disclaimer

This page is for general information only and does not constitute procurement, financial, clinical, legal or regulatory advice. Benchmarking methods, data sources, normalisation approaches and comparator availability vary by organisation, health system and country, and change over time. Always follow your own governance and financial procedures, and consult qualified procurement, finance, clinical and regulatory professionals for decisions specific to your organisation. medigear.uk accepts no liability for actions taken based on this content.